NCT02677155 2021-03-01
Lymvac-2
Oslo University Hospital
Phase 2 Completed
Clinical Trials
5 trialsNCT00481832 2018-02-14
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma
Stanford University
Phase 2 Terminated
NCT01939730 2015-11-04
Rituximab + GM-CSF in Patients With Follicular B-Cell Lymphoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00505921 2011-11-16
Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00001237 2008-03-04
Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas
National Institutes of Health Clinical Center (CC)
Phase 2 Completed